193: First Case of Vancomycin Resistent Bacteremia (VRE) With Acute Interstitial Nephritis (AIN)

2009 ◽  
Vol 53 (4) ◽  
pp. B71
2004 ◽  
Vol 44 (2) ◽  
pp. e25-e27 ◽  
Author(s):  
Michel Tintillier ◽  
Lotti Kirch ◽  
Carole Almpanis ◽  
Jean-Pierre Cosyns ◽  
Jean-Michel Pochet ◽  
...  

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Ha Nee Jang ◽  
Sehyun Jung ◽  
Seunghye Lee ◽  
Se-Ho Chang ◽  
Tae Won Lee ◽  
...  

Abstract Background The Japanese chaff flower, Achyranthes japonica, is used as complementary medicine to control degenerative arthritis. Although commonly used in South Korea, there has been no report of side effects. We report the first case of acute interstitial nephritis (AIN) that occurred in a woman who ingested A. japonica extract for 4 months. Case presentation A 56-year-old Korean woman was admitted for deterioration of renal function. She had general weakness and nausea for 1 month. Her initial blood urea nitrogen and serum creatinine levels were 26.3 mg/dL and 3.2 mg/dL, respectively. She acknowledged ingesting A. japonica extract for the past 4 months. Renal histology demonstrated AIN represented by immune cell infiltration into the interstitium, tubulitis, and tubular atrophy, but the glomeruli were intact. A. japonica was discontinued immediately and conservative management was started. Renal function was nearly restored to the baseline level without medication after 13 months. Conclusion This is a rare case report of AIN associated with a pure A. japonica extract. In the case of unknown etiology of AIN, physicians should ask about the use of herbal medicines, nutraceuticals, and traditional folk medicines including A. japonica.


2016 ◽  
Vol 2016 ◽  
pp. 1-3 ◽  
Author(s):  
Léonard Golbin ◽  
Thibault Dolley-Hitze ◽  
Nolwenn Lorcy ◽  
Nathalie Rioux-Leclercq ◽  
Cécile Vigneau

Background. Acute interstitial nephritis (AIN) is a frequent cause of Acute Kidney Injury (AKI). Drug hypersensitivity is the most common etiology and the list of drugs that can induce AIN is not exhaustive yet.Case Report. Here, we describe the case of a 43-year-old man who was treated with nifedipine (Adalate®) for Raynaud’s syndrome. After nifedipine introduction, serum creatininemia progressively increased from 91 to 188 μmol/L in a few months and AKI was diagnosed. Laboratory work-up results indicated the presence of tubular proteinuria and nonspecific inflammatory syndrome. Histological analysis found granulomatous interstitial nephropathy without necrosis in 20% of the kidney biopsy without immunofluorescent deposit. Nifedipine was stopped and corticosteroid treatment was started with a rapid but incomplete reduction of serum creatininemia level to 106 μmol/L.Conclusion. This is the first case of AIN caused by nifedipine.


Nefrología ◽  
2021 ◽  
Author(s):  
Rui Barata ◽  
Bernardo Marques da Costa ◽  
David Navarro ◽  
Marco Mendes ◽  
Cecília Silva ◽  
...  

2020 ◽  
Vol 8 ◽  
pp. 2050313X2091002 ◽  
Author(s):  
Umut Selamet ◽  
Ramy M Hanna ◽  
Anthony Sisk ◽  
Lama Abdelnour ◽  
Lena Ghobry ◽  
...  

Drug-induced lupus erythematosus has features distinct from primary systemic lupus erythematosus. It can occur with a wide variety of agents that result in the generation of anti-histone or other types of antibodies. Systemic manifestations of drug-induced systemic lupus erythematosus may include renal dysfunction due to circulating immune complexes or due to other immune reactions to the culprit medication(s). Acute interstitial nephritis occurs due to DNA–drug or protein–drug complexes that trigger an allergic immune response. We report a patient who developed acute kidney injury, rash, and drug-induced systemic lupus diagnosed by serologies after starting chlorthalidone and amiodarone. A renal biopsy showed acute interstitial nephritis and not lupus-induced glomerulonephritis. It is important to note that systemic lupus erythematosus and acute interstitial nephritis can occur together, and this report highlights the role of the kidney biopsy in ascertaining the pathological diagnosis and outlining therapy in drug-induced lupus erythematosus.


1987 ◽  
Vol 26 (2) ◽  
pp. 230-233 ◽  
Author(s):  
Noboru TAZOE ◽  
Nobuhiko IKEZAKI ◽  
Jiro ITO ◽  
Kuniharu KUWAHARA ◽  
Michiaki HARA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document